Lexaria Bioscience Corp. (LEXX)’s price-to-cash and price-to-free cash flow ratios

The price of Lexaria Bioscience Corp. (NASDAQ: LEXX) closed at $0.78 in the last session, up 13.21% from day before closing price of $0.69. In other words, the price has increased by $+0.0911 from its previous closing price. On the day, 1658850 shares were traded. LEXX stock price reached its highest trading level at $0.8800 during the session, while it also had its lowest trading level at $0.7030.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.



We take a closer look at LEXX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 17.90 and its Current Ratio is at 17.90. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 09 when TURKEL CATHERINE C. bought 1,500 shares for $2.84 per share. The transaction valued at 4,267 led to the insider holds 1,500 shares of the business.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LEXX now has a Market Capitalization of 13.05M and an Enterprise Value of 9.54M. For the stock, the TTM Price-to-Sale (P/S) ratio is 18.37 while its Price-to-Book (P/B) ratio in mrq is 0.93. Its current Enterprise Value per Revenue stands at 27.46 whereas that against EBITDA is -1.39.

Stock Price History:

Over the past 52 weeks, LEXX has reached a high of $3.60, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is 1.9469, while the 200-Day Moving Average is calculated to be 2.5036.

Shares Statistics:

According to the various share statistics, LEXX traded on average about 109.48K shares per day over the past 3-months and 561.58k shares per day over the past 10 days. A total of 5.95M shares are outstanding, with a floating share count of 4.89M. Insiders hold about 5.20% of the company’s shares, while institutions hold 11.60% stake in the company. Shares short for LEXX as of Apr 27, 2023 were 303.77k with a Short Ratio of 0.30M, compared to 338.53k on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 5.07% and a Short% of Float of 5.66%.

Earnings Estimates

The company has 0 analysts who recommend its stock at the moment. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$0.22. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.

Analysts are recommending an EPS of between -$1.07 and -$1.07 for the fiscal current year, implying an average EPS of -$1.07. EPS for the following year is -$0.84, with 1 analysts recommending between -$0.84 and -$0.84.

Revenue Estimates

A total of 1 analysts have provided revenue estimates for LEXX’s current fiscal year. The highest revenue estimate was $450k, while the lowest revenue estimate was $450k, resulting in an average revenue estimate of $450k. In the same quarter a year ago, actual revenue was $255k, up 76.50% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $1.13M in the next fiscal year. The high estimate is $1.13M and the low estimate is $1.13M. The average revenue growth estimate for next year is up 151.10% from the average revenue estimate for this year.